Jefferies downgrades Milestone to hold, cites product launch concerns (MIST)
Rasi Bhadramani Jefferies has downgraded their rating on Milestone Pharmaceuticals (NASDAQ:MIST) to hold, citing concerns about the commercial opportunity for ...
Rasi Bhadramani Jefferies has downgraded their rating on Milestone Pharmaceuticals (NASDAQ:MIST) to hold, citing concerns about the commercial opportunity for ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.